Skip to content

Harrow HROW Intangible Purchases

Intangible Purchases at other companies

Bausch Health Companies logo
Bausch Health CompaniesBHC
$38M+322%
Organon logo
OrganonOGN
$0-100%
Ultragenyx Pharmaceutical logo
Ultragenyx PharmaceuticalRARE
$5M-66.7%

Other financials

Income statement

See full
Revenue$44.2M-7.6%
Gross profit$27.0M-16.3%
Operating income-$22.1M-96.6%
Net income-$27.6M-55.2%
EPS (diluted)-$0.74-48.0%

Balance sheet

See full
Cash & equivalents$94.6M+41.8%
Total debt$308.6M-32.9%
Total equity$28.7M-49.1%
Total assets$419.5M+15.2%

Cash flow

See full
Operating cash flow-$9.0M-146%
CapEx$194.0K+14.1%
Free cash flow-$9.2M-147%

Valuation

See full
Market cap$1.59B+38.4%
Enterprise value$1.81B+13.8%
P/S5.9×+0.5×

Profitability

See full
Gross margin74.1%-0.4pp
Operating margin7.3%+5.2pp
Net margin-19.8%+18.0pp
FCF margin5.7%+5.0pp

Returns & leverage

See full
Return on equity-50%+17.5pp
Debt / equity10.7×+2.6×
Current ratio2.5×+1.6×

Where this comes from

Reported directly by Harrow in its filing.

Tagged under the XBRL concept us-gaap:PaymentsToAcquireIntangibleAssets.

The official record: Harrow’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about Harrow's intangible purchases.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Harrow's intangible purchases?
Harrow (HROW) reported intangible purchases of $9K in Q1 2026.
How has Harrow's intangible purchases changed year-over-year?
Harrow's intangible purchases decreased by 78.6% year-over-year, from $42K to $9K.
What is the long-term trend for Harrow's intangible purchases?
Over 3 years (2021 to 2024), Harrow's intangible purchases has grown at a 0.8% compound annual growth rate (CAGR), from $84K to $86K.
What does intangible purchases mean?
Cash spent acquiring intangible assets such as patents, licenses, and other intellectual property.